With special thanks to:
Prof. Dr. Poukens and Prof. Dr. van der Hulst being the pioneers of our first PSI development, Prof. Dr. Dr. Kessler and Dr. Dr. Lethaus for continuing this work within the MUMC+. To Paul Laeven, Frank Spee, Paul Verjans, Yordy de Bruijn and Richard van den Boorn for technological developments. Frans Smeets, Marc Schoenmakers & Paul Kwant for facilitating during the start and David Koper for co-founding.
Next to that I would like to thank all the people involved as well as the parties presented:
Maastricht Instruments (MI) is a high-tech company that focuses on developing innovative and market-oriented solutions for SMEs and academic and industrial R&D institutes. Our multidisciplinary team specialises in technological developments for the field of medicine and life sciences.
DEE is committed to becoming a technological enabler by facilitating the MUMC+ in its core tasks of research, education and healthcare provision. By developing commercially unavailable technology, we make it possible for researchers to apply new research methods and conduct unique research studies. This enables researchers to become innovative frontrunners in the field of scientific research, which in turn serves to enhance the significance of the MUMC+ as a research institute. With our maintenance activities (repairs, maintenance, registration and safety), we are simultaneously able to safeguard the operating life and safety of the equipment used in research and education.
Brightlands Chemelot Campus B.V.
Brightlands Chemelot Campus is a world-leading innovation location and home to a vibrant and fast-growing open community of groundbreaking companies and knowledge institutes.It offers state of the art R&D and manufacturing infrastructures, on-campus education and science-oriented business support, venture capital, and business development services.
Maastricht UMC-Holding was created especially for innovative companies in the fields of Health, Medicine and Life Sciences.The holding company is the parent company of commercial companies that have originated from Maastricht UMC+. Thanks to the holding company, commercial research initiatives are allocated a clear position within the core tasks of Maastricht UMC+.
The core project activities include the development of new biomaterials and rapid manufacturing technologies that will allow innovative customised implants to be delivered to surgeons within a 48 hour time frame.
Maastricht University (UM),Leading in Learning, the most international university in the Netherlands, stands out for its innovative approach to learning and international outlook. With 15,000 students and 3,500 staff, UM offers a wide choice of academic programmes, all of which are designed to bring out the best in its students.
‘The patient is the centre point’ is a slogan that we, like many other hospitals, have been using for some time. After all, our work, our care, revolves around you as a patient. But how do you experience being a focal point? How do you feel about the way we address you and your relatives or visitors? In the near future we will be paying extra attention to our client-focus.